Tuesday, November 17, 2026

Kirin's New Business: Collaboration with Takada Pharmaceutical on a Leftover Drug Service for Dispensing Pharmacies! AI to support inventory management operations

Kirin Holdings will welcome Takata Pharmaceutical as a collaborative partner for "premedi," a prescription drug placement service for dispensing pharmacies, starting in November 2023, and will begin a trial of "premedi" sales support by Takata Pharmaceutical!
Kirin Holdings aims to expand the number of "premedi" outlets to 300*1 by the end of 2024, six times the current number, and to 2,000 by 2027, in order to solve social issues for more dispensing pharmacies and patients.

New businesses created through the Kirin Business Challenge

This service is a new business born out of the Kirin Business Challenge, Kirin's in-house business solicitation system that aims to create innovation in business domains ranging from food to medicine. Through the development of this business, we aim to solve the problems of dispensing pharmacies and patients, especially small and medium-sized ones, and to grow our business in the health science field.
1 Number of stores as of October 31, 2023: 50 stores

What is "premedi"?

Background of Service Development
In dispensing pharmacies, infrequently handled drugs are sometimes out of stock and cannot be provided according to the prescription or take time to arrange and are not given to patients until the next day or later. Our survey revealed that 44% patients across Japan have experienced not receiving the drug they prescribed, and 35% of them have changed their pharmacy because their impression of the pharmacy worsened. 2

On the other hand, according to a survey by the Ministry of Health, Labour and Welfare, more than 200,000 yen*3 per store per year is disposed of as surplus inventory at dispensing pharmacies due to expiration or other reasons. 4

For small- and medium-sized dispensing pharmacies in particular, it is a difficult management issue to balance stocking an excess or shortage of infrequently handled pharmaceuticals and minimizing waste.

Service Features
premedi" is a prescription drug service for dispensing pharmacies that uses AI to predict the probability of drug use at each pharmacy and can order approximately 100 different types of drugs in small lots of 10 to 30 tablets. The service is characterized by its ability to appropriately manage the inventory of pharmaceuticals that are handled infrequently at each dispensing pharmacy, and "premedi" purchases pharmaceuticals that are approaching their expiration date and replaces them with new ones.

With the introduction of this service, dispensing pharmacies will be able to deliver even infrequently handled drugs to patients as prescribed, thereby reducing excess inventory. In addition, by reducing the time and effort required by pharmacies to secure pharmaceuticals, pharmacists will have more time to perform their primary duties, such as providing medication guidance.

2 Kirin survey, October 2022 web-based questionnaire Target: Men and women in their 30-70s (N=10,000)
3 Monthly average of the amount of discarded pharmaceuticals to insurance pharmacies by the Ministry of Health, Labor and Welfare: 19,230 yen in 2017 and 21,808 yen in 2018.
4 Questionnaire survey on the current status and reduction of immovable inventory drugs in insurance pharmacies (cited from J-STAGE, 2019)

https://www.jstage.jst.go.jp/article/yakkyoku/11/2/11_nt.2019-1905/_pdf/-char/ja

Future Development
The test rollout of "premedi" began on Tuesday, April 26, 2022, mainly in the Tokyo metropolitan area. We have received several comments from dispensing pharmacies that "missing products were prevented," "patients were not kept waiting," and "employees (pharmacists) are able to use their time for their primary duties," confirming the need for "premedi," so we began nationwide deployment at the end of 2022.

In November 2023, Takata Pharmaceutical, a generic drug developer with added value in terms of ease-of-use and ease-of-take, will be invited as a collaborative partner to further expand this service, and Takata Pharmaceutical will begin a trial to support "premedi" sales.

Through the expansion of "premedi", Kirin will further promote the CSV*6 management that the Kirin Group has set forth by creating a state where even small and medium-sized dispensing pharmacies can immediately receive a variety of medicines, thereby solving issues faced by dispensing pharmacies and patients, promoting "family pharmacists and pharmacies" as stated in the "Vision of Pharmacies for Patients "*5 of the Ministry of Health, Labour and Welfare, and realizing economic value. " and economic value, and further promote the Kirin Group's CSV*6 management.

5 Ministry of Health, Labour and Welfare, "Vision of Pharmacies for Patients" (Friday, October 23, 2015)https://www.mhlw.go.jp/file/04-Houdouhappyou-11121000-Iyakushokuhinkyoku-Soumuka/vision_1.pdf

6 Abbreviation for Creating Shared Value. Creating value that can be shared with customers and society.
 The Kirin Group will contribute to the realization of a spiritually rich society by expanding new joys in "food and health" through manufacturing that focuses on nature and people.

Reference: Press release on "PREMEDI" (Tuesday, April 26, 2022)https://www.kirinholdings.com/jp/newsroom/release/2022/0426_01.html

Business Overview of "premedi

1. service name "premedihttps://premedi.kirin.co.jp/
2. Provided by Kirin Holdings Company, Limited
3. Service Description: AI-based prescription medicine service that responds to urgent prescriptions for pharmaceuticals
The AI will select a list of drugs that each dispensing pharmacy does not have in stock and that are likely to be needed by patients. The list is used to make a final decision*1 on the drugs to be purchased at the dispensing pharmacy. 1. Selection from a list of ethical drugs that is determined on a case-by-case basis.
Storage shelves for selected pharmaceuticals are available for rent. Pharmaceuticals can be purchased in small lots from our pharmaceutical distribution partners.
Used portions can be easily ordered online and replenished.
Pharmaceuticals that are approaching their expiration date can be purchased by the sales partner*2, so that a sufficient supply of expired pharmaceuticals is always available. Dispensing pharmacies can simultaneously reduce inventory risk and shortage risk of infrequently handled drugs.
2 Purchase by pharmaceutical sales partners is limited to pharmaceuticals that meet the conditions specified separately.

About Takata Pharmaceuticals

Takada Pharmaceutical Co., Ltd. is a research-based company that is primarily engaged in the research, development, manufacturing, and marketing of pharmaceutical products, with the management philosophy of "contributing to human health through the development of original products and the appropriate supply of high-quality products," including value-added generic drugs with strength in the pediatric field. The company is mainly engaged in research and development, manufacturing, and sales of pharmaceutical products as an R&D-oriented company.

name of companyTakata Pharmaceutical Co.
EstablishmentNovember 1928
Location1-11-1 Numakage, Minami-ku, Saitama City, Saitama Prefecture
representativeHiroki Takada, President and Representative Director
Business OverviewManufacture and sales of pharmaceuticals, soft drinks and health foods
uniform resouce locatorhttps://www.takata-seiyaku.co.jp/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。